Market Analysis and Insights:
The global Clinical Mass Spectrometry market is valued at US$ 760.3 million in 2020. The market size will reach US$ 1484 million by the end of 2027, growing at a CAGR of 10.1% during 2021-2027.
Scope and Segment:
Clinical Mass Spectrometry market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Mass Spectrometry market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.
By Company
- Danaher
- Bruker
- Agilent
- Thermo Fisher
- Waters
- Shidmazu
- Perkin Elmer
Segment by Type
- LC-MS
- MALDI-TOF MS
- Others
Segment by Application
- Clinical Diagnostics
- Clinical Research
Segment by Region
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
TABLE OF CONTENTS
1 STUDY COVERAGE
- 1.1 Clinical Mass Spectrometry Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Type
- 1.2.2 LC-MS
- 1.2.3 MALDI-TOF MS
- 1.3 Market by Application
- 1.3.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Application
- 1.3.2 Clinical Diagnostics
- 1.3.3 Clinical Research
- 1.4 Study Objectives
- 1.5 Years Considered
2 EXECUTIVE SUMMARY
- 2.1 Global Clinical Mass Spectrometry Sales Estimates and Forecasts 2016-2027
- 2.2 Global Clinical Mass Spectrometry Revenue Estimates and Forecasts 2016-2027
- 2.3 Global Clinical Mass Spectrometry Revenue by Region: 2016 VS 2021 VS 2027
- 2.4 Global Top Clinical Mass Spectrometry Regions by Sales
- 2.4.1 Global Top Clinical Mass Spectrometry Regions by Sales (2016-2021)
- 2.4.2 Global Top Clinical Mass Spectrometry Regions by Sales (2022-2027)
- 2.5 Global Top Clinical Mass Spectrometry Regions by Revenue
- 2.5.1 Global Top Clinical Mass Spectrometry Regions by Revenue (2016-2021)
- 2.5.2 Global Top Clinical Mass Spectrometry Regions by Revenue (2022-2027)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 South America
- 2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS
- 3.1 Global Clinical Mass Spectrometry Sales by Manufacturers
- 3.1.1 Global Top Clinical Mass Spectrometry Manufacturers by Sales (2019-2021)
- 3.1.2 Global Top Clinical Mass Spectrometry Manufacturers Market Share by Sales (2019-2021)
- 3.1.3 Global Top Companies by Clinical Mass Spectrometry Sales in 2020
- 3.2 Global Clinical Mass Spectrometry Revenue by Manufacturers
- 3.2.1 Global Top Clinical Mass Spectrometry Manufacturers by Revenue (2019-2021)
- 3.2.2 Global Top Clinical Mass Spectrometry Manufacturers Market Share by Revenue (2019-2021)
- 3.2.3 Global Top Companies by Clinical Mass Spectrometry Revenue in 2020
- 3.3 Global Clinical Mass Spectrometry Sales Price by Manufacturers
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Clinical Mass Spectrometry Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
- 4.1 Global Clinical Mass Spectrometry Sales by Type
- 4.1.1 Global Clinical Mass Spectrometry Historical Sales by Type (2016-2021)
- 4.1.2 Global Clinical Mass Spectrometry Forecasted Sales by Type (2022-2027)
- 4.1.3 Global Clinical Mass Spectrometry Sales Market Share by Type (2016-2027)
- 4.2 Global Clinical Mass Spectrometry Revenue by Type
- 4.2.1 Global Clinical Mass Spectrometry Historical Revenue by Type (2016-2021)
- 4.2.2 Global Clinical Mass Spectrometry Forecasted Revenue by Type (2022-2027)
- 4.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Type (2016-2027)
- 4.3 Global Clinical Mass Spectrometry Price by Type
- 4.3.1 Global Clinical Mass Spectrometry Price by Type (2016-2021)
- 4.3.2 Global Clinical Mass Spectrometry Price Forecast by Type (2022-2027)
5 MARKET SIZE BY APPLICATION
- 5.1 Global Clinical Mass Spectrometry Sales by Application
- 5.1.1 Global Clinical Mass Spectrometry Historical Sales by Application (2016-2021)
- 5.1.2 Global Clinical Mass Spectrometry Forecasted Sales by Application (2022-2027)
- 5.1.3 Global Clinical Mass Spectrometry Sales Market Share by Application (2016-2027)
- 5.2 Global Clinical Mass Spectrometry Revenue by Application
- 5.2.1 Global Clinical Mass Spectrometry Historical Revenue by Application (2016-2021)
- 5.2.2 Global Clinical Mass Spectrometry Forecasted Revenue by Application (2022-2027)
- 5.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Application (2016-2027)
- 5.3 Global Clinical Mass Spectrometry Price by Application
- 5.3.1 Global Clinical Mass Spectrometry Price by Application (2016-2021)
- 5.3.2 Global Clinical Mass Spectrometry Price Forecast by Application (2022-2027)
6 NORTH AMERICA
- 6.1 North America Clinical Mass Spectrometry Market Size by Type
- 6.1.1 North America Clinical Mass Spectrometry Sales by Type (2016-2027)
- 6.1.2 North America Clinical Mass Spectrometry Revenue by Type (2016-2027)
- 6.2 North America Clinical Mass Spectrometry Market Size by Application
- 6.3 North America Clinical Mass Spectrometry Market Size by Country
- 6.3.1 North America Clinical Mass Spectrometry Sales by Country (2016-2027)
- 6.3.2 North America Clinical Mass Spectrometry Revenue by Country (2016-2027)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
7 EUROPE
- 7.1 Europe Clinical Mass Spectrometry Market Size by Type
- 7.1.1 Europe Clinical Mass Spectrometry Sales by Type (2016-2027)
- 7.1.2 Europe Clinical Mass Spectrometry Revenue by Type (2016-2027)
- 7.2 Europe Clinical Mass Spectrometry Market Size by Application
- 7.3 Europe Clinical Mass Spectrometry Market Size by Country
- 7.3.1 Europe Clinical Mass Spectrometry Sales by Country (2016-2027)
- 7.3.2 Europe Clinical Mass Spectrometry Revenue by Country (2016-2027)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 ASIA PACIFIC
- 8.1 Asia Pacific Clinical Mass Spectrometry Market Size by Type
- 8.1.1 Asia Pacific Clinical Mass Spectrometry Sales by Type (2016-2027)
- 8.1.2 Asia Pacific Clinical Mass Spectrometry Revenue by Type (2016-2027)
- 8.2 Asia Pacific Clinical Mass Spectrometry Market Size by Application
- 8.3 Asia Pacific Clinical Mass Spectrometry Market Size by Region
- 8.3.1 Asia Pacific Clinical Mass Spectrometry Sales by Region (2016-2027)
- 8.3.2 Asia Pacific Clinical Mass Spectrometry Revenue by Region (2016-2027)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Southeast Asia
9 SOUTH AMERICA
- 9.1 South America Clinical Mass Spectrometry Market Size by Type
- 9.1.1 South America Clinical Mass Spectrometry Sales by Type (2016-2027)
- 9.1.2 South America Clinical Mass Spectrometry Revenue by Type (2016-2027)
- 9.2 South America Clinical Mass Spectrometry Market Size by Application
- 9.3 South America Clinical Mass Spectrometry Market Size by Country
- 9.3.1 South America Clinical Mass Spectrometry Sales by Country (2016-2027)
- 9.3.2 South America Clinical Mass Spectrometry Revenue by Country (2016-2027)
- 9.3.3 Brazil
10 MIDDLE EAST AND AFRICA
- 10.1 Middle East and Africa Clinical Mass Spectrometry Market Size by Type
- 10.1.1 Middle East and Africa Clinical Mass Spectrometry Sales by Type (2016-2027)
- 10.1.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Type (2016-2027)
- 10.2 Middle East and Africa Clinical Mass Spectrometry Market Size by Application
- 10.3 Middle East and Africa Clinical Mass Spectrometry Market Size by Country
- 10.3.1 Middle East and Africa Clinical Mass Spectrometry Sales by Country (2016-2027)
- 10.3.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2016-2027)
- 10.3.3 Middle East
- 10.3.4 Africa
11 COMPANY PROFILES
- 11.1 Danaher
- 11.1.1 Company Profile
- 11.1.2 Product Picture and Specifications
- 11.1.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.1.4 Contact Information
- 11.2 Bruker
- 11.2.1 Company Profile
- 11.2.2 Product Picture and Specifications
- 11.2.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.2.4 Contact Information
- 11.3 Agilent
- 11.3.1 Company Profile
- 11.3.2 Product Picture and Specifications
- 11.3.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.3.4 Contact Information
- 11.4 Thermo Fisher
- 11.4.1 Company Profile
- 11.4.2 Product Picture and Specifications
- 11.4.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.4.4 Contact Information
- 11.5 Waters
- 11.5.1 Company Profile
- 11.5.2 Product Picture and Specifications
- 11.5.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.5.4 Contact Information
- 11.6 Shimadzu
- 11.6.1 Company Profile
- 11.6.2 Product Picture and Specifications
- 11.6.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.6.4 Contact Information
- 11.7 PerkinElmer
- 11.7.1 Company Profile
- 11.7.2 Product Picture and Specifications
- 11.7.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share
- 11.7.4 Contact Information
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
- 12.1 Clinical Mass Spectrometry Value Chain Analysis
- 12.2 Clinical Mass Spectrometry Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Clinical Mass Spectrometry Production Mode & Process
- 12.4 Clinical Mass Spectrometry Sales and Marketing
- 12.4.1 Clinical Mass Spectrometry Sales Channels
- 12.4.2 Clinical Mass Spectrometry Distributors
- 12.5 Clinical Mass Spectrometry Customers
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 13.1 Clinical Mass Spectrometry Industry Trends
- 13.2 Market Opportunities and Drivers
- 13.3 Market Challenges
- 13.4 Porter's Five Forces Analysis
14 KEY FINDINGS IN THE GLOBAL CLINICAL MASS SPECTROMETRY STUDY
15 APPENDIX
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer